A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

NCT06341335 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric and Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: cadonilimab
DRUG: pulocimab
DRUG: paclitaxel
DRUG: placebo

Sponsor

Akeso